AAM Opposes Oregon’s SB 764 Settlements Bill

Association Says ‘Unnecessary’ Legislation Will Delay Access And Drive Up Prices

gavel medicines
AAM opposes Oregon SB 764 legislation, citing same constitutional defects as California pay-for-delay law • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin